Aurisco Pharmaceutical Co.,Ltd

Aurisco Pharmaceutical Co.,Ltd company information, Employees & Contact Information

Aurisco Pharmaceutical Co., Ltd. was founded in 1998, focusing on the production and sales of complex APIs, FDFs and CRDMO of oligonucleotide APIs. It has been listed on the main board of Shanghai Stock Exchange since 2020 (stock code 605116). The company currently has 3 factories, 6 R&D centers, more than 1,300 employees and around 240 R&D personnel. It takes a leading position in the field of complex synthesis, synthetic biology, oligonucleotide synthesis, photochemistry and other fields and has become a long-term partner of many world-renowned pharmaceutical companies. With international compliant quality system, sufficient production capacity, global sales network, we are able to provide high-quality products and efficient services to customers around the world. Email: info@aurisco.com  Website: http://www.aurisco.com/

Company Details

Employees
34
Founded
-
Address
Shanghai, Cn
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Shanghai
Looking for a particular Aurisco Pharmaceutical Co.,Ltd employee's phone or email?

Aurisco Pharmaceutical Co.,ltd Questions

News

Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides - Fierce Pharma

Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides Fierce Pharma

Aurisco's Busy Business Development - PR Newswire

Aurisco's Busy Business Development PR Newswire

China GLP-1s: Novo Nordisk invests $556m, Aurisco expands - BioProcess International

China GLP-1s: Novo Nordisk invests $556m, Aurisco expands BioProcess International

Copper-Mediated Oxidative Coupling of Difluoromethyl Bromides/Chlorides with Primary Amines: Direct Synthesis of α-Ketoamides - ACS Publications

Copper-Mediated Oxidative Coupling of Difluoromethyl Bromides/Chlorides with Primary Amines: Direct Synthesis of α-Ketoamides ACS Publications

Successful FDA inspection at Aurisco’s manufacturing site in Yangzhou, China - BioSpace

Successful FDA inspection at Aurisco’s manufacturing site in Yangzhou, China BioSpace

Aurisco to Build Oligonucleotides Manufacturing Facility in China - Contract Pharma

Aurisco to Build Oligonucleotides Manufacturing Facility in China Contract Pharma

Fiocruz and Hypera Pharma to produce medication for Spinal Muscular Atrophy - Fundação Oswaldo Cruz (Fiocruz)

Fiocruz and Hypera Pharma to produce medication for Spinal Muscular Atrophy Fundação Oswaldo Cruz (Fiocruz)

Aurisco gets Auxiton® (Dydrogesterone) as first generic approval in China - BioSpace

Aurisco gets Auxiton® (Dydrogesterone) as first generic approval in China BioSpace

Aurisco’s Manufacturing Site in China Clears FDA Inspection - Contract Pharma

Aurisco’s Manufacturing Site in China Clears FDA Inspection Contract Pharma

Top Aurisco Pharmaceutical Co.,Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant